Voyager Therapeutics Inc (NASDAQ: VYGR) stock closed at $6.86 on 11/29/24 after a major increase of 18.7%. Moreover, unusually high trading volume at 196% of normal accompanied the advance. The stock has risen 28.0% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Voyager Therapeutics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Voyager Therapeutics has a neutral Appreciation Score of 41 but a very low Power Rating of 7, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment